Assenagon Asset Management S.A. Grows Position in The Cooper Companies, Inc. $COO

Assenagon Asset Management S.A. boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4,342.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 271,305 shares of the medical device company’s stock after buying an additional 265,198 shares during the period. Assenagon Asset Management S.A. owned 0.14% of Cooper Companies worth $22,236,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bell Investment Advisors Inc boosted its stake in Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after purchasing an additional 219 shares during the period. True Wealth Design LLC grew its position in Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the last quarter. Board of the Pension Protection Fund acquired a new position in Cooper Companies in the fourth quarter valued at $41,000. CYBER HORNET ETFs LLC purchased a new stake in shares of Cooper Companies in the second quarter valued at about $36,000. Finally, MUFG Securities EMEA plc purchased a new stake in shares of Cooper Companies in the second quarter valued at about $42,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on COO shares. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a report on Wednesday, March 4th. Robert W. Baird upped their price objective on Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research note on Friday, December 5th. Mizuho set a $100.00 price objective on Cooper Companies and gave the stock an “outperform” rating in a research report on Friday, December 5th. William Blair upgraded Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Finally, Wells Fargo & Company boosted their target price on Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a report on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $90.79.

Cooper Companies Stock Up 0.1%

Shares of NASDAQ COO opened at $71.54 on Friday. The stock has a market capitalization of $13.96 billion, a price-to-earnings ratio of 35.42, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $89.83. The firm has a 50-day moving average price of $79.07 and a 200 day moving average price of $76.10. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the prior year, the business posted $0.92 earnings per share. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.